H ere, we demonstrate the electrophysiological findings for a preterm baby who was referred to our center for therapy of persistent complex arrhythmia with heart rate (HR) varying between 60 and 300 bpm. The ECG showed polymorphic ventricular tachycardia (HR 280 bpm), including short runs of torsade de pointes alternating within a few seconds with bradycardia due to third-grade atrioventricular (AV) block (HR 78 bpm, atrial rate 135 bpm), together with broad QRS complexes of 90 ms 1/2 ( Figure 1 and Data Supplement). During bradycardia, an extreme prolongation of the normalized QT interval (QTc 760 ms 1/2 ) was present ( Figure 2 ). To control tachycardia, treatment with propranolol was given intravenously, resulting in a predominant 2:1 AV block (HR 68 bpm) and fewer episodes of nonsustained ventricular tachycardia ( Figure 3 and Data Supplement), although QTc remained unchanged (740 ms 1/2 ). Because of the persisting unstable hemodynamic condition, the extreme QTc prolongation combined with AV block, and the QRS and T-wave morphology, a sporadic defect in the Na ϩ Ch-encoding SCN5A gene was suspected. Thus, an additional treatment with the Na ϩ Ch blocker mexiletine was initiated. With this medication, sinus rhythm occurred within 90 minutes. Furthermore, within 3 hours, a significant improvement of QTc (760 to 480 ms 1/2 ) and of the intraventricular conduction delay (QRS 90 to 50 ms 1/2 ) occurred ( Figure 4 ). Genetic examination of the child confirmed the suspected long-QT syndrome-3 with proof of a de novo SCN5A gene defect (P1332L) close to the central opening of the Na ϩ channel.
Our ECG tracings and the child's clinical course (further details are given in the Data Supplement) confirmed the concept that the Na ϩ Ch blocker mexiletine is capable of shortening the prolonged ventricular refractoriness below the P-P interval in extreme long-QT syndrome-3 with lifethreatening arrhythmia. A, Acute response after 90 minutes showing a significant reduction in QT duration with shortening of the ventricular refractoriness, allowing the establishment of a regular sinus rhythm. Note the fusion of T and the consecutive P wave and the monomorphic QRS complexes (50 ms 1/2 ). B, Follow-up ECG tracing recorded after 15 months of therapy. Note further reduction in QT duration, which could be achieved only with a high-dose treatment of mexiletine (16 mg/kg per day in 3 doses).
Figure 2.
Six-lead ECG of the same patient during a bradycardic episode in which extreme prolongation of QT interval (as long as 760 ms 1/2 ) is detectable. The third-grade AV block (HR 78 bpm, atrial rate 135 bpm) is due to the ventricular refractoriness. Polymorphic QRS complexes resulting from variant intraventricular conduction delays lead to different QRS durations up to 90 ms 1/2 .
